Aralez Bio is a startup based in the United States, most recent round Series A, 1 tracked investor.
Aralez Bio is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Aralez Bio develops and manufactures noncanonical amino acids using a pioneering enzymatic platform to support peptide therapeutics discovery and manufacturing with sustainable, scalable biocatalysis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.